Subtype
Primary Malignant Liver Neoplasm
CI-CAN-00006507Explore in graph →
807 active trials14 approved drugs17 evidence items
- NCIt
- C34803
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00006507Explore in graph →
Clinical trials
3,489 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (403)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02878109 | DCE-MRI for Assessment of Response to TACE of HCC(DCE-MRI) | completed | — | 40 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT02774161 | B-mode Ultrasound Imaging in Detecting Early Liver Cancer | completed | N/A | 45 | Stanford UniversityOTHER | 1 | Aug 3, 2021 | clinicaltrials |
| NCT01126463 | 188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas(LIP-RE-I) | completed | Phase 1 | 16 | Center Eugene MarquisOTHER | 1 | Aug 2, 2021 | clinicaltrials |
| NCT03767764 | Yliver as a Test to Early Diagnose HCC(YliverDIAG) | completed | — | 190 | Corporacion Parc TauliOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT03645655 | PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants(PIVKA-II) | completed | — | 257 | Shanghai Children's Medical CenterOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT00261378 | Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation(PRECISIONV) | completed | Phase 2 | 212 | Boston Scientific CorporationINDUSTRY | 4 | Jul 21, 2021 | clinicaltrials |
| NCT03200171 | Effect of DAAs on Behavior of HCC in HCV Patients | completed | — | 300 | Al-Azhar UniversityOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT03291379 | Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies(VEROnA) | completed | Early Phase 1 | 8 | Boston Scientific CorporationINDUSTRY | 1 | Jul 19, 2021 | clinicaltrials |
| NCT03707080 | Direct Acting Antiviral-Post Authorization Safety Study | completed | — | 42 | Target PharmaSolutions, Inc.INDUSTRY | 5 | Jul 6, 2021 | clinicaltrials |
| NCT03245190 | Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 27 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Jun 18, 2021 | clinicaltrials |
| NCT02292173 | Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer | completed | Phase 1 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 10, 2021 | clinicaltrials |
| NCT03267641 | Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma(PLANET) | completed | — | 86 | National Cancer Centre, SingaporeOTHER | 4 | Jun 9, 2021 | clinicaltrials |
| NCT01655693 | Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma(ReLive) | completed | Phase 3 | 397 | Valerio TherapeuticsINDUSTRY | 11 | Jun 2, 2021 | clinicaltrials |
| NCT01271504 | E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 102 | Eisai Inc.INDUSTRY | 6 | May 12, 2021 | clinicaltrials |
| NCT02859324 | A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 21 | CelgeneINDUSTRY | 4 | May 11, 2021 | clinicaltrials |
| NCT01908426 | Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib(CELESTIAL) | completed | Phase 3 | 707 | ExelixisINDUSTRY | 19 | May 6, 2021 | clinicaltrials |
| NCT02472249 | Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT02973204 | Circulating Tumor Cells and Tumor DNA in HCC and NET | completed | — | 167 | University of AarhusOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT03295006 | A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC(TARGET) | completed | — | 209 | Boston Scientific CorporationINDUSTRY | 8 | Apr 21, 2021 | clinicaltrials |
| NCT03706742 | STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention | completed | N/A | 12,386 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 20, 2021 | clinicaltrials |
| NCT03741088 | Study to Evaluate VORTX Rx (Theresa)(Theresa) | completed | N/A | 8 | HistoSonics, Inc.INDUSTRY | 1 | Apr 20, 2021 | clinicaltrials |
| NCT04844112 | CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation | completed | N/A | 139 | Seoul National University HospitalOTHER | 0 | Apr 14, 2021 | clinicaltrials |
| NCT03851471 | Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma | completed | Early Phase 1 | 10 | Zhong WangOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT01033240 | CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer | completed | Phase 2 | 172 | Daiichi SankyoINDUSTRY | 4 | Apr 8, 2021 | clinicaltrials |
| NCT01915589 | Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 16 | BayerINDUSTRY | 17 | Apr 8, 2021 | clinicaltrials |
| NCT01915602 | Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 14 | BayerINDUSTRY | 21 | Apr 8, 2021 | clinicaltrials |
| NCT00877136 | A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® | completed | — | 18 | St. Joseph Hospital of OrangeOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT01755767 | Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy(METIV-HCC) | completed | Phase 3 | 383 | Daiichi SankyoINDUSTRY | 16 | Apr 6, 2021 | clinicaltrials |
| NCT02953743 | Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 25 | Eisai Co., Ltd.INDUSTRY | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04820712 | Surgical Therapy and Survival in HCC/ C.F. Zhang et al. | completed | — | 664 | Linzhu ZhaiOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT02670122 | Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC | completed | — | 131 | Instituto de Investigación Sanitaria de la Fundación Jiménez DíazOTHER | 1 | Mar 30, 2021 | clinicaltrials |
| NCT03888859 | ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma | completed | Early Phase 1 | 12 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT01967823 | T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Mar 24, 2021 | clinicaltrials |
| NCT04813861 | Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation(CELPerCutCHC) | completed | — | 57 | Central Hospital, Nancy, FranceOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03375281 | Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique | completed | N/A | 140 | Seoul National University HospitalOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT02832882 | RFA for Small HCC With No-touch Technique Using Octopus Electrode | completed | N/A | 118 | Seoul National University HospitalOTHER | 0 | Mar 22, 2021 | clinicaltrials |
| NCT03389126 | Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment(AvelumabHCC) | completed | Phase 2 | 30 | Seoul National University HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT02642913 | Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients | completed | Phase 1 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04780789 | Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization | completed | — | 61 | Brno University HospitalOTHER | 0 | Mar 4, 2021 | clinicaltrials |
| NCT03405909 | Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study(ESCULAP) | completed | — | 517 | University Hospital ErlangenOTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT02693847 | Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients | completed | — | 446 | Hospital Universitario de ValmeOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT03338062 | A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy | completed | N/A | 15 | Indiana UniversityOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04771988 | Radioembolization for Hepatocellular Carcinoma With Portal Vein Tumoral Thrombosis | completed | — | 17 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 0 | Feb 25, 2021 | clinicaltrials |
| NCT02273739 | Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation | completed | Phase 1 / Phase 2 | 21 | CelgeneINDUSTRY | 2 | Feb 23, 2021 | clinicaltrials |
| NCT02337465 | KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer | completed | N/A | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT03254121 | Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response(HEPCASUS) | completed | — | 93 | Karolinska InstitutetOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03382327 | Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas(3D-HAPPI) | completed | N/A | 136 | IHU StrasbourgOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT04230642 | Multicenter Study to Evaluate a New Robotic Device for Image-guided Percutaneous Needle Placement | completed | N/A | 22 | Quantum SurgicalINDUSTRY | 1 | Feb 4, 2021 | clinicaltrials |
| NCT04072679 | Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 1, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Aug 6, 2021source: clinicaltrials